RecruitingPHASE2, PHASE3NCT05669820

Antisecretory Factor Glioblastoma Phase 2

Studying Giant cell glioblastoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peter Siesjö
Principal Investigator
Charlotte Edwardsson
Skane University Hospital
Intervention
Salovum(dietary_supplement)
Enrollment
300 enrolled
Eligibility
18-75 years · All sexes
Timeline
20242027

Study locations (1)

Collaborators

Lund University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05669820 on ClinicalTrials.gov

Other trials for Giant cell glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Giant cell glioblastoma

← Back to all trials